Read Time: 4 minutes
Today in
, researchers at Huntsman Cancer Institute at the University of Utah report critical new insights into how cells mount an attack against melanoma tumors.
Melanoma is an aggressive type of skin cancer that can arise from excess exposure to sun, frequent sunburns, genetics, and other environmental factors. Melanoma, like all cancers, begins within cells. Specially designed and refined over billions of years, cells are experts at working to root out and fix routine errors that arise. A tumor begins when a cell makes faulty copies of itself over and over again. If left unchecked, these faulty cell copies continue to grow into complex ecosystems that become tumors. Some tumors, like melanomas, can go on to develop mechanisms to sustain themselves with blood flow and oxygen. They can also send the cancerous cells through the body to proliferate in other organs, which ultimately causes death.
Credit: Huntsman Cancer Institute
SALT LAKE CITY - Today in
Nature Communications, researchers at Huntsman Cancer Institute at the University of Utah report critical new insights into how cells mount an attack against melanoma tumors.
Melanoma is an aggressive type of skin cancer that can arise from excess exposure to sun, frequent sunburns, genetics, and other environmental factors. Melanoma, like all cancers, begins within cells. Specially designed and refined over billions of years, cells are experts at working to root out and fix routine errors that arise. A tumor begins when a cell makes faulty copies of itself over and over again. If left unchecked, these faulty cell copies continue to grow into complex ecosystems that become tumors. Some tumors, like melanomas, can go on to develop mechanisms to sustain themselves with blood flow and oxygen. They can also send the cancerous cells through the body to proliferate in other organs, which ultimately causes death.
Read Time: 5 minutes
Huntsman Cancer Institute
In recognition of exceptional service including scientific achievements, training, and scholarly accomplishments, faculty at Huntsman Cancer Institute (HCI) at the University of Utah (U of U) have recently received honors for their work. HCI congratulates faculty who have recently been honored with new or renewed endowed chairs and professorships, as well as a faculty member who was recently recognized as a distinguished professor at the U of U.
Endowed chairs at HCI play an important role in creating a partnership between donors and researchers. These chairs can provide resources to attract and retain top faculty, fund lab trainees, and support innovative research.
Read Time: 3 minutes
Kola Okuyemi, MD, MPH
Huntsman Cancer Institute (HCI) at the University of Utah (U of U) has appointed Kola Okuyemi, MD, MPH, as executive director of equity, diversity, and inclusion. In this role, Okuyemi will oversee efforts across HCI’s research, clinical care, community engagement, and education programs to actively counter racism and promote a culture of belonging, a key strategic priority for the cancer center.
Okuyemi has had a distinguished career as a National Institutes of Health-funded researcher advancing work to eliminate health disparities and improve health in refugee and underserved populations. Okuyemi joined the University of Utah in 2017 as professor and chair of family and preventive medicine. Okuyemi has served as HCI senior director of diversity and inclusion and HCI Research Executive Committee member since 2017, roles in which he has overseen equitable access to clinical research as part of the leadership of HCI’s NCI-designated co
Published: May 07, 2021
-Xenter’s Expanding Team of Industry Leaders Poised to Advance Device/Data/Drug Technologies for Interventional Medicine, Pharmaceutical Advancements and Digital Health-
SALT LAKE CITY (BUSINESS WIRE) Xenter, Inc. (XenterMD.com), the world’s first start-up Device-Data-Drug healthcare technologies company, today announced the appointment of four additional industry leaders to its Board of Directors and the closing of a $12M Series A offering of preferred stock. The additional members are
Robert S. Langer, an Institute Professor at MIT and the most cited engineer in history and 4th most cited individual in any field who has authored more than 1,500 scientific papers. He is also a co-founder and board member of Moderna.